Lixin Wang

1.4k total citations
35 papers, 1.0k citations indexed

About

Lixin Wang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Lixin Wang has authored 35 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Lixin Wang's work include Peptidase Inhibition and Analysis (5 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Cells and Metastasis (2 papers). Lixin Wang is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Cancer Cells and Metastasis (2 papers). Lixin Wang collaborates with scholars based in China, United States and Australia. Lixin Wang's co-authors include Didier Merlin, Shanthi V. Sitaraman, Andrew T. Gewirtz, Baljit Walia, Kevin A. Janes, Joan S. Brugge, John P. Evans, Jesse Roman, Vasantha L. Kolachala and Pallavi Garg and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Lixin Wang

31 papers receiving 997 citations

Peers

Lixin Wang
Comparison fields: 5 of 92
  • Molecular Biology 431
  • Oncology 286
  • Immunology 219
  • Cancer Research 194
  • Genetics 164
Replace Dennis Kobelt with:
Dennis Kobelt Germany
Manolis Roulis United States
Hanna Rokita Poland
Zailong Qin China
Bijan Ansari United Kingdom
Mark Baer United States
Melanie J. McConnell New Zealand
Keunhee Oh South Korea
Dennis Kobelt Germany View profile →
Citations per field, relative to Lixin Wang
Lixin Wang · 1×
Citations per year, relative to Lixin Wang
Lixin Wang · 1×

Countries citing papers authored by Lixin Wang

Since Specialization
Citations

This map shows the geographic impact of Lixin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin Wang more than expected).

Fields of papers citing papers by Lixin Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin Wang. The network helps show where Lixin Wang may publish in the future.

Co-authorship network of co-authors of Lixin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin Wang. A scholar is included among the top collaborators of Lixin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin Wang. Lixin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 3
4 1
5 3
6 4
7 6
8 7
9 9
10 25
11 93
12 3
13 27
14 33
15 38
16 20
17 62
18 231
19 193
20 8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026